Can a vascular occlusion occur with platelet‑rich plasma (PRP) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Vascular Occlusion Occur with PRP Injections?

Yes, vascular occlusion can occur with PRP injections, though it is extremely rare—documented cases involve catastrophic outcomes including permanent blindness and orbital ischemia from inadvertent arterial injection.

Risk Context and Mechanism

While PRP is generally considered safe for aesthetic applications 1, severe vascular complications have been reported when PRP is inadvertently injected into facial arteries 2, 3. The mechanism involves retrograde embolization through the supratrochlear or supraorbital arteries into the ophthalmic artery, causing:

  • Complete ophthalmic artery occlusion
  • Anterior and posterior segment ischemia
  • Extraocular muscle ischemia
  • Optic nerve infarction
  • Cerebral infarction (frontal, parietal, occipital lobes)
  • Phthisis bulbi (eventual eye shrinkage)

One case documented a 49-year-old woman who developed immediate permanent blindness after glabellar PRP injection 2, and another 37-year-old woman lost consciousness immediately after forehead injection with subsequent complete vision loss and eventual phthisis 3.

Safety Profile Compared to Other Injectables

PRP complications overall are similar to corticosteroids and hyaluronic acid, but significantly higher than placebo 4. In a meta-analysis of knee osteoarthritis injections:

  • PRP complication rate: 18.66%
  • Comparison group: 9.14%
  • Number needed to harm: 11
  • However, most complications were mild to moderate and self-limiting

The consensus from international experts confirms that autologous/allogeneic sterile PRP preparations are clinically safe when properly administered 1.

Critical Safety Technique: Intradermal Injection

The safest PRP injection technique is precise intradermal delivery, which avoids the deep underlying vasculature in the hypodermis 5. Key safety markers:

  • Formation of a visible papule with blanching confirms intradermal placement
  • Use 30-gauge, 4mm needles
  • Bevel facing upward
  • Inject 5mm apart
  • This technique "delivers APCs in a very safe manner" and does not place product into deep vasculature 5

Common Pitfalls to Avoid

  1. Never inject deeply into facial tissues where arterial structures lie (glabellar region, forehead, periocular areas are highest risk)
  2. Avoid using large bore needles for facial injections (use 30G for intradermal, maximum 25G for deeper Bio-Filler applications) 5
  3. Do not inject rapidly or with high pressure which increases risk of arterial penetration
  4. Recognize danger zones: glabellar region, medial forehead, periocular areas where supratrochlear/supraorbital arteries are superficial

Clinical Caveat

There is currently no validated therapy for ophthalmic artery occlusion from PRP embolism 3. If vision changes occur during or immediately after injection:

  • This is a medical emergency
  • Immediate referral to facilities with ophthalmology and stroke protocols
  • Prognosis for vision recovery is extremely poor once occlusion occurs

Bottom Line

While vascular occlusion with PRP is rare, when it occurs in facial aesthetic applications, outcomes are catastrophic and irreversible. The risk is virtually eliminated by using proper intradermal technique with papule formation, avoiding deep injection into vascular planes, and respecting high-risk anatomical zones.

Related Questions

What is the best antibiotic to use after a platelet‑rich plasma (PRP) knee injection?
Can platelet‑rich plasma (PRP) be frozen using the same protocol as platelet‑poor plasma (PPP)—i.e., snap‑freeze on dry ice or liquid nitrogen, or directly in a –80 °C or –20 °C freezer—and then thawed in a water bath before use?
Does alcohol consumption affect the efficacy of platelet‑rich plasma (PRP) therapy after the injection?
For a 26‑year‑old patient with pubalgia, is platelet‑rich plasma (PRP) injection into the left internal obturator insertion an appropriate treatment, and what protocol would you recommend?
Can a platelet-rich plasma (PRP) injection cause lymph node swelling and flu-like symptoms?
How should a dobutamine infusion be tapered in a patient with decompensated heart failure who is currently receiving 7 µg/kg/min?
What is the recommended treatment for a patient with right medial ankle pain due to flat feet?
What are the indications, recommended dosing regimen, monitoring requirements, and contraindications for Olaparib in adult patients with confirmed germline or somatic BRCA1/2 mutations (or other homologous recombination repair deficiency) who have ovarian, breast, pancreatic, or prostate cancer?
What are the effects, benefits, and risks of guanfacine and fluoxetine (Prozac) in a 10‑year‑old child?
Is discharge from the emergency department appropriate for a patient with acute gout and a C‑reactive protein level of 28 mg/L?
In peritoneal dialysis patients, which situations or conditions contraindicate the use of non‑dihydropyridine calcium‑channel blockers (verapamil, diltiazem)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.